| Company/Division name | Kodak |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 300 |
| Year reshoring announced: | 2020 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 765 |
| Country(ies) from which reshored: | China,India |
| City reshored to: | Rochester |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | ingredients for generic drugs, hydroxychloroquine |
| What non-domestic negative factors made offshoring less attractive? | Green considerations, Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, essential product supply, covid |
| Government Incentive dollar amount: | 765 |
